Stocks to buy or sell: Dharmesh Shah of ICICI Securities suggests buying Sun Pharma shares on 12 May 2025 | Stock Market News

Stocks to buy or sell: Dharmesh Shah of ICICI Securities suggests buying Sun Pharma shares on 12 May 2025 | Stock Market News

Source: Live Mint Stock market news: Indian stock markets in the week ahead, starting Monday, will be influenced by geopolitical events, especially the ongoing tensions with Pakistan, along with macroeconomic indicators and corporate earnings, according to market analysts. The Nifty 50 wrapped up the week at 24,008.00, reflecting a decrease of 1.39%, while the Sensex…

Read More
Stocks to buy or sell: Dharmesh Shah of ICICI Securities suggests buying Sun Pharma shares on 5 May 2025 | Stock Market News

Stocks to buy or sell: Dharmesh Shah of ICICI Securities suggests buying Sun Pharma shares on 5 May 2025 | Stock Market News

Source: Live Mint Stock market news: The domestic equity market benchmark indices, Sensex and Nifty 50, saw a minor uptick on Friday, ending off day’s high, as investors resorted to profit-booking at higher levels. Optimism surrounding a potential India-US trade deal, record high April GST collection, and continuous inflow of foreign funds, was offset by…

Read More
Sun Pharma to acquire Nasdaq-listed Checkpoint Therapeutics for 5 million; shares edge higher | Stock Market News

Sun Pharma to acquire Nasdaq-listed Checkpoint Therapeutics for $355 million; shares edge higher | Stock Market News

Source: Live Mint Sun Pharmaceutical Industries Ltd. has announced the acquisition of Nasdaq-listed Checkpoint Therapeutics, Inc., an immunotherapy and targeted oncology company, in a $355 million cash deal. The acquisition will bolster Sun Pharma’s onco-dermatology portfolio, adding Checkpoint’s recently FDA-approved cancer drug, UNLOXCYT (cosibelimab-ipdl), to its pipeline. The deal, expected to close in the second…

Read More